Works matching AU Fox, Robert J
Results: 120
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
- Published in:
- Journal of Neuroimaging, 2014, v. 24, n. 6, p. 569, doi. 10.1111/jon.12082
- By:
- Publication type:
- Article
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 6, p. 699, doi. 10.1001/jamaneurol.2021.0688
- By:
- Publication type:
- Article
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 5, p. 558, doi. 10.1001/jamaneurol.2021.0405
- By:
- Publication type:
- Article
Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 3, p. 351, doi. 10.1001/jamaneurol.2020.4689
- By:
- Publication type:
- Article
Tissue Markers for Acute Multiple Sclerosis Treatment Response—A Step Toward Personalized Medicine.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 4, p. 406, doi. 10.1001/jamaneurol.2017.4850
- By:
- Publication type:
- Article
Web-Based Self-Management for Patients with Multiple Sclerosis: A Practical, Randomized Trial.
- Published in:
- Telemedicine & e-Health, 2011, v. 17, n. 1, p. 5, doi. 10.1089/tmj.2010.0133
- By:
- Publication type:
- Article
Overcoming barriers to informed consent in neurological research: Perspectives from a national survey.
- Published in:
- Research Ethics, 2023, v. 19, n. 1, p. 42, doi. 10.1177/17470161221131497
- By:
- Publication type:
- Article
Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
- Published in:
- Current Medical Research & Opinion, 2014, v. 30, n. 4, p. 613, doi. 10.1185/03007995.2013.863755
- By:
- Publication type:
- Article
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
- Published in:
- Current Medical Research & Opinion, 2014, v. 30, n. 2, p. 251, doi. 10.1185/03007995.2013.849236
- By:
- Publication type:
- Article
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study
- Published in:
- CNS Drugs, 2023, v. 37, n. 3, p. 275, doi. 10.1007/s40263-022-00982-6
- By:
- Publication type:
- Article
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.
- Published in:
- Multiple Sclerosis Journal, 2025, v. 31, n. 2, p. 159, doi. 10.1177/13524585241303489
- By:
- Publication type:
- Article
Using serum neurofilament-light in clinical practice: Growing enthusiasm that may need bridling.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 369, doi. 10.1177/13524585231224702
- By:
- Publication type:
- Article
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 35, doi. 10.1177/13524585231213164
- By:
- Publication type:
- Article
Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1257, doi. 10.1177/13524585231187289
- By:
- Publication type:
- Article
The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 846, doi. 10.1177/13524585231172490
- By:
- Publication type:
- Article
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 427, doi. 10.1177/13524585221140270
- By:
- Publication type:
- Article
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1591, doi. 10.1177/13524585221083194
- By:
- Publication type:
- Article
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1526, doi. 10.1177/13524585221076717
- By:
- Publication type:
- Article
Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 801, doi. 10.1177/13524585211037909
- By:
- Publication type:
- Article
DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 2, p. 187, doi. 10.1177/13524585211049073
- By:
- Publication type:
- Article
Sensitivity of T1/T2-weighted ratio in detection of cortical demyelination is similar to magnetization transfer ratio using post-mortem MRI.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 2, p. 198, doi. 10.1177/13524585211014760
- By:
- Publication type:
- Article
Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 16, doi. 10.1177/13524585211059766
- By:
- Publication type:
- Article
Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray–white matter junction correlates with iron-enriched macrophages.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2159, doi. 10.1177/1352458521999651
- By:
- Publication type:
- Article
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2014, doi. 10.1177/1352458520986956
- By:
- Publication type:
- Article
Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1781, doi. 10.1177/1352458520981370
- By:
- Publication type:
- Article
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1564, doi. 10.1177/1352458520971819
- By:
- Publication type:
- Article
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1384, doi. 10.1177/1352458520964409
- By:
- Publication type:
- Article
Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 742, doi. 10.1177/1352458520936214
- By:
- Publication type:
- Article
New applications for independent activities of daily living in measuring disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 97, doi. 10.1177/1352458519898591
- By:
- Publication type:
- Article
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 12, p. 1581, doi. 10.1177/1352458519867314
- By:
- Publication type:
- Article
Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1102, doi. 10.1177/1352458519852722
- By:
- Publication type:
- Article
Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 976, doi. 10.1177/1352458519845836
- By:
- Publication type:
- Article
The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Preferred Sources of Health Information in Persons With Multiple Sclerosis: Degree of Trust and Information Sought.
- Published in:
- Journal of Medical Internet Research, 2013, v. 15, n. 4, p. 1, doi. 10.2196/jmir.2466
- By:
- Publication type:
- Article
JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155897
- By:
- Publication type:
- Article
Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147863
- By:
- Publication type:
- Article
T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 5, p. 637, doi. 10.1002/ana.23860
- By:
- Publication type:
- Article
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
- Published in:
- Annals of Neurology, 2012, v. 72, n. 6, p. 918, doi. 10.1002/ana.23693
- By:
- Publication type:
- Article
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 3, p. 445, doi. 10.1002/ana.22337
- By:
- Publication type:
- Article
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial.
- Published in:
- Annals of Neurology, 2008, v. 63, n. 3, p. 395, doi. 10.1002/ana.21363
- By:
- Publication type:
- Article
Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
- Published in:
- Annals of Neurology, 2007, v. 62, n. 3, p. 219, doi. 10.1002/ana.21113
- By:
- Publication type:
- Article
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 3, p. 478
- By:
- Publication type:
- Article
Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2147588, doi. 10.1001/jamanetworkopen.2021.47588
- By:
- Publication type:
- Article
The Future of Research in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 8, p. 853, doi. 10.1001/jamaneurol.2015.0270
- By:
- Publication type:
- Article
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 3, p. 833, doi. 10.1007/s40120-023-00461-0
- By:
- Publication type:
- Article